Charlotte Lyen

Charlotte Lyen (nee Allcock) is a Senior Manager and Clinical Trial Lead at Biogen since August 2020, with prior experience as a Clinical Project Manager at NIGHTSTAR THERAPEUTICS until its acquisition by Biogen in July 2020. Previous roles include Clinical Trial Manager (Contract) at Gilead Sciences and Clinical Project Manager at St. Stephen's AIDS Trust, where responsibilities included roles as a Junior Project Manager. Charlotte's career began at Cancer Research UK, progressing through various positions including Senior Clinical Research Associate. Educational credentials include a BSc in Neuroscience from the University of Nottingham and a sandwich year lab placement at the University of Melbourne focused on spinal cord injury and neural stem cell culture.